1h Free Analyst Time
Global Cancer Gene Therapy Market 2021-2025Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the cancer gene therapy market and it is poised to grow by $ 2.96 bn during 2021-2025 progressing at a CAGR of 20% during the forecast period. The report on cancer gene therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the side effects of traditional cancer treatments, benefits associated with gene therapy for cancer treatment and the rising prevalence rate of cancer boosting the demand for cancer therapeutics. In addition, the side effects of traditional cancer treatments is anticipated to boost the growth of the market as well.
The cancer gene therapy market analysis includes application segments and geographical landscapes.
The cancer gene therapy market is segmented as below:
By Application
- Oncolytic virotherapy
- Gene transfer
- Gene-induced immunotherapy
By Geographical Landscapes
- North America
- Europe
- Asia
- ROW
This study identifies the rising partnerships and collaborations as one of the prime reasons driving the cancer gene therapy market growth during the next few years. Also, favorable government regulations for gene therapy programs and rapid growth potential in developing economies will lead to sizable demand in the market.
The report on cancer gene therapy market covers the following areas:
- Cancer gene therapy market sizing
- Cancer gene therapy market forecast
- Cancer gene therapy market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cancer gene therapy market vendors that include Adaptimmune Therapeutics plc, Advantagene Inc., Amgen Inc., Anchiano Therapeutics Ltd., bluebird bio Inc., GlaxoSmithKline Plc, Merck KGaA, Shanghai Sunway Biotech Co. Ltd., Sibiono GeneTech Co. Ltd. Shenzhen (Sibiono), and ZIOPHARM Oncology Inc. . Also, the cancer gene therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Therapy
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Exhibit
Executive Summary
The publisher recognizes the following companies as the key players in the global cancer gene therapy market: Adaptimmune Therapeutics plc, Advantagene Inc., Amgen Inc., Anchiano Therapeutics Ltd., bluebird bio Inc., GlaxoSmithKline Plc, Merck KGaA, Shanghai Sunway Biotech Co. Ltd., Sibiono GeneTech Co. Ltd. Shenzhen (Sibiono), and ZIOPHARM Oncology Inc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rising partnerships and collaborations.'
According to the report, one of the major drivers for this market is the side effects of traditional cancer treatments.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Adaptimmune Therapeutics plc
- Advantagene Inc.
- Amgen Inc.
- Anchiano Therapeutics Ltd.
- bluebird bio Inc.
- GlaxoSmithKline Plc
- Merck KGaA
- Shanghai Sunway Biotech Co. Ltd.
- Sibiono GeneTech Co. Ltd. Shenzhen (Sibiono)
- ZIOPHARM Oncology Inc.